Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study

Subcutaneous administration of ceftriaxone was associated with PK/PD and dosage requirements comparable to those of intravenous administration, supporting the use of subcutaneous ceftriaxone in older patients.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-05-30
DOI
https://doi.org/10.1093/ofid/ofaf313
Citations
5
Primary Topic
Pharmacological Effects and Toxicity Studies
Type
article
Field-Weighted Citation Impact
17.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study

N. Weil, Alexandre Gueremy, Sabine Drevet, Dominique Breilh et al.
5 citations
Open Forum Infectious Diseases
Pharmacological Effects and Toxicity Studies
17.47
article

Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study

N. Weil, Alexandre Gueremy, Sabine Drevet, Dominique Breilh, E. Mériglier, Louise Allan, B. de la Gastine, Hélène Domergue, Paul Chabert, Jean‐Philippe Lanoix, Elise Thiel, Guillaume Albaret, Catherine Bioteau, Alain Putot, G. Gavazzi, Marie Froidure, Françoise Stanke‐Labesque, Claire Roubaud‐Baudron, Didier Brönnimann, Anne-Laure Destrem, Nicolas Grégoire, Pauline Caraux-Paz, Thomas Brunet, H. Chaussade, Margaux Isnard, Marion Le Maréchal, Héloïse Fauchon, Emilie Clabé, Patricia Pavèse, Claire Gledel, Sylvain Gaujard, Cyprien Arlaud, Giuseppina Lanfranchi, Sylvain Goutelle, N. Baclet, Armelle Leperre, Isabelle Pierre, Marc Paccalin, Tristan Ferry, E F, Cécile Pouderoux, Alexie Bosch, Peggy Blanc, Caroline Hyernart, Youri Chauleur, Sophie Schir
article en
5 citations

Abstract

Subcutaneous administration of ceftriaxone was associated with PK/PD and dosage requirements comparable to those of intravenous administration, supporting the use of subcutaneous ceftriaxone in older patients.

Open Forum Infectious DiseasesVol. 12(6)
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Lyon College (US), Centre Hospitalier Universitaire de Grenoble (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Université de Poitiers (FR), Hospices Civils de Lyon (FR), Bordeaux Population Health (FR), Centre Hospitalier Métropole Savoie (FR), Hôpital Saint-André (FR), Centre Hospitalier Universitaire de Poitiers (FR), Polyclinique de Bordeaux-Tondu (FR), Laboratoire de Biométrie et Biologie Evolutive (FR), BoRdeaux Institute of onCology (FR), Université Grenoble Alpes (FR)
OPEC Fund for International Development, Fondation Innovations en Infectiologie, Fondation de France
Good health and well-being
Openalex Percentile: Top 1%
Pharmacological Effects and Toxicity Studies
17.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.